{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:48:08Z","timestamp":1782366488620,"version":"3.54.5"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Epidemiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) are two independent leading causes of morbidity and death, with co-existence contributing substantially to morbidity and deaths among aging populations. Despite growing evidence on the impact of COPD-CVD co-existence, little is known about COPD-CHD co-morbidity, as other previous studies mostly examine CVD as a single aggregated health outcome, obscuring disease-specific trajectories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess 5-year national trends and sociodemographic disparities in the prevalence of coexisting CHD-COPD co-morbidity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using the 2020\u22122024 National Health Interview Survey Integrated Public Use Microdata Series adults' dataset, we estimated the national prevalence of CHD-COPD co-morbidity. Weighted descriptive statistics, multivariate regression models, and sensitivity analysis were used to examine the associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      CHD-COPD co-morbidity prevalence showed no statistically significant increase from 2020 to 2024; although the estimated linear trend was positive, it did not reach statistical significance (OR per 1-year increase\u2009=\u20091.04; 95% CI: 0.997\u20131.08;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.072). Age, sex, body mass index, race\/ethnicity, geographical region, smoking status, insurance status, income, and educational attainment were strong independent predictors of CHD-COPD co-morbidity. Older age (aOR: 1.004; 95% CI: 1.003\u20131.004,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.0001) was independently associated with higher odds; current and former smokers had approximately 5\u20136 times higher odds of CHD-COPD co-morbidity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CHD-COPD co-morbidity is a rare but clinically significant condition, with a stable adjusted prevalence of approximately 0.35%\u20130.43% annually among United States adults from 2020 to 2024. Smoking, older age, male sex, lower income, and Southern residence were the strongest independent predictors of CHD-COPD co-morbidity. These findings underscore the need for integrated, sociodemographically targeted prevention and chronic-disease management strategies addressing shared cardiopulmonary risk factors, particularly tobacco use, across vulnerable populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fepid.2026.1840095","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:30:40Z","timestamp":1782365440000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Coronary heart disease and chronic obstructive pulmonary disease prevalence and temporal trends among United States adults: a national population-based study"],"prefix":"10.3389","volume":"6","author":[{"given":"Muinat Abolore","family":"Idris","sequence":"first","affiliation":[{"name":"Department of Health Promotion and Behavioral Sciences, School of Public Health, The University of Texas Health Science Center at Houston","place":["Houston, TX, United States"]},{"name":"Department of Environmental & Occupational Health Sciences, School of Public Health, The University of Texas Health Science Center at Houston","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie M.","family":"Valenzuela","sequence":"additional","affiliation":[{"name":"Department of Environmental & Occupational Health Sciences, School of Public Health, The University of Texas Health Science Center at Houston","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Aguilera","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Behavioral Sciences, School of Public Health, The University of Texas Health Science Center at Houston","place":["Houston, TX, United States"]},{"name":"Department of Environmental & Occupational Health Sciences, School of Public Health, The University of Texas Health Science Center at Houston","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"B1","volume-title":"Chronic Disease Indicators. COPD","year":"2024"},{"key":"B2","volume-title":"Chronic Obstructive Pulmonary Disease (COPD)","year":""},{"key":"B3","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.2147\/COPD.S365771","article-title":"New perspectives on chronic obstructive pulmonary disease","volume":"17","author":"Celli","year":"2022","journal-title":"Int J of Chron Obstruct Pulmon Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"175346581775052","DOI":"10.1177\/1753465817750524","article-title":"Defining the relationship between COPD and CVD: what are the implications for clinical practice?","volume":"12","author":"Morgan","year":"2018","journal-title":"Ther Adv Respir Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"106736","DOI":"10.1016\/j.ejim.2026.106736","article-title":"Chronic obstructive pulmonary disease (COPD) and cardiovascular comorbidities: shedding light on key interactions and therapeutic approaches","volume":"147","author":"Stella","year":"2026","journal-title":"Eur J of Intern Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0265682","DOI":"10.1371\/journal.pone.0265682","article-title":"Factors associated with coronary heart disease in COPD patients and controls","volume":"17","author":"Svendsen","year":"2022","journal-title":"PLoS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12890-023-02606-1","article-title":"Association between chronic obstructive pulmonary disease and cardiovascular disease in adults aged 40 years and above: data from NHANES 2013\u20132018","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Pulm Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e000302","DOI":"10.1136\/bmjresp-2018-000302","article-title":"Risk and temporal order of disease diagnosis of comorbidities in patients with COPD: a population health perspective","volume":"5","author":"T\u00e9nyi","year":"2018","journal-title":"BMJ Open Respir Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S2213-2600(23)00261-8","article-title":"COPD And multimorbidity: recognising and addressing a syndemic occurrence","volume":"11","author":"Fabbri","year":"2023","journal-title":"Lancet Respir Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"27082","DOI":"10.1038\/s41598-025-12580-9","article-title":"Disease network analysis to reveal comorbidity patterns in hospitalized patients with COPD using large-scale administrative health data","volume":"15","author":"Li","year":"2025","journal-title":"Sci Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"01289","DOI":"10.1183\/23120541.01289-2024","article-title":"Comorbidity profiles in chronic obstructive pulmonary disease: a multicohort study","volume":"11","author":"Egerod","year":"2024","journal-title":"ERJ Open Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0317592","DOI":"10.1371\/journal.pone.0317592","article-title":"Mortality trends and disparities for coexisting chronic obstructive pulmonary disease and cardiovascular disease: a retrospective analysis of deaths in the United States from 1999 to 2020","volume":"20","author":"Goyal","year":"2025","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.amjms.2024.11.002","article-title":"Cardiovascular diseases-related mortality among adults with comorbid chronic obstructive pulmonary disease in the United States","volume":"369","author":"Qamar","year":"2025","journal-title":"Am J Med Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"100937","DOI":"10.1016\/j.lanwpc.2023.100937","article-title":"Sociodemographic correlates with 659 prevalence of comorbidities in patients with chronic obstructive pulmonary disease: a study from a Chinese national survey","volume":"42","author":"Huang","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"B15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/COPD.S495326","article-title":"Research status and direction of chronic obstructive pulmonary disease complicated with coronary heart disease: a bibliometric analysis from 2005 to 2024","volume":"20","author":"Bian","year":"2025","journal-title":"Int J Chron Obstruct Pulmon"},{"key":"B16","doi-asserted-by":"publisher","first-page":"175346662211136","DOI":"10.1177\/17534666221113647","article-title":"Association of COPD exacerbations and acute cardiovascular events: a systematic review and meta-analysis","volume":"16","author":"M\u00fcllerov\u00e1","year":"2022","journal-title":"Ther Adv Respir Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e001798","DOI":"10.1136\/bmjresp-2023-001798","article-title":"Comorbidities and mortality among patients with chronic obstructive pulmonary disease","volume":"10","author":"Skajaa","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"B18","volume-title":"Heart Disease Facts","year":"2024"},{"key":"B19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejim.2025.01.016","article-title":"Risk trajectory of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"135","author":"Pirera","year":"2025","journal-title":"Eur J Intern Med"},{"key":"B20","volume-title":"IPUMS Health Surveys: National Health Interview Survey, Version 8.1 [dataset]","author":"Blewett","year":"2025"},{"key":"B21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.124.068295","article-title":"Health economics of cardiovascular disease in the United States","volume":"150","author":"Maddox","year":"2024","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"79.","DOI":"10.3389\/fcvm.2019.00079","article-title":"Karma of cardiovascular disease risk factors for prevention and management of major cardiovascular events in the context of acute exacerbations of chronic obstructive pulmonary disease","volume":"6","author":"Crisan","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3322\/caac.21586","article-title":"Understanding and addressing social determinants to advance cancer health equity in the United States: a blueprint for practice, research, and policy","volume":"70","author":"Alcaraz","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15620\/cdc\/174596","article-title":"Chronic obstructive pulmonary disease in adults age 18 and older: United States, 2023","volume":"674","author":"Weeks","year":"2025","journal-title":"NCHS Data Brie"},{"key":"B26","first-page":"289","article-title":"Employment and activity limitations among adults with COPD\u2014united States, 2013","volume":"64","author":"Wheaton","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e256834","DOI":"10.1001\/jamanetworkopen.2025.6834","article-title":"State and sociodemographic trends in US cigarette smoking with future projections","volume":"8","author":"Stone","year":"2025","journal-title":"JAMA Netw Open"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1433269","DOI":"10.3389\/fpubh.2024.1433269","article-title":"Effects of smoking cessation on individuals with COPD: a systematic review and meta-analysis","volume":"12","author":"Wang","year":"2024","journal-title":"Front Public Health."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.2147\/COPD.S466280","article-title":"Temporal dynamics of cardiovascular risk in patients with chronic obstructive pulmonary disease during stable disease and exacerbations: review of the mechanisms and implications","volume":"19","author":"Simons","year":"2024","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1001\/jama.2019.16932","article-title":"Life expectancy and mortality rates in the United States, 1959\u20132017","volume":"322","author":"Woolf","year":"2019","journal-title":"JAMA"},{"key":"B31","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s11524-013-9847-2","article-title":"Widening rural-urban disparities in all-cause mortality and mortality from major causes of death in the USA, 1969\u20132009","volume":"91","author":"Singh","year":"2014","journal-title":"J Urban Health"},{"key":"B32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.22158\/rhs.v5n1p48","article-title":"Race, ethnicity, socioeconomic Status, and chronic lung disease in the U.S","volume":"5","author":"Assari","year":"2020","journal-title":"Res Health Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/healthcare6020062","article-title":"Poverty status and childhood asthma in white and black families: national survey of Children's Health","volume":"6","author":"Assari","year":"2018","journal-title":"Healthcare (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/1874192402014010005","article-title":"Diminished returns of educational attainmenton heart disease among black Americans","volume":"14","author":"Assari","year":"2020","journal-title":"Open Cardiovasc Med J"},{"key":"B35","volume-title":"U.S. Health in International Perspective: Shorter Lives, Poorer Health","author":"Woolf","year":"2013"},{"key":"B36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11892-018-1032-2","article-title":"Neighborhood environments and diabetes risk and control","volume":"18","author":"Bilal","year":"2018","journal-title":"Curr Diab Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.21106\/ijma.236","article-title":"Social determinants of health in the United States: addressing major health inequality trends for the nation, 1935\u20132016","volume":"6","author":"Singh","year":"2017","journal-title":"Int J MCH AIDS"}],"container-title":["Frontiers in Epidemiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fepid.2026.1840095\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T05:30:42Z","timestamp":1782365442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fepid.2026.1840095\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":37,"alternative-id":["10.3389\/fepid.2026.1840095"],"URL":"https:\/\/doi.org\/10.3389\/fepid.2026.1840095","relation":{},"ISSN":["2674-1199"],"issn-type":[{"value":"2674-1199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"article-number":"1840095"}}